The Medical Advisor

Abstract   Pancreatic cancer remains one of the most lethal malignancies, often diagnosed at advanced stages with limited treatment options. Recent studies and anecdotal reports suggest that repurposed drugs and alternative therapies may offer new hope for improving patient outcomes. This review examines emerging evidence on ivermectin, fenbendazole, high-dose vitamin C, and hydroxychloroquine as potential adjunct therapeutic agents for pancreatic cancer. While preliminary findings are promising, further clinical trials are necessary to establish their efficacy and safety. Keywords: Pancreatic cancer, ivermectin, fenbendazole, vitamin D, hydroxychloroquine, repurposed drugs, chemotherapy, high-dose vitamin C, immunotherapy Pancreatic Cancer Awareness 1. Introduction   Approaches to improve pancreatic cancer therapy are essential as this disease has a very bleak outcome. Appr...

Prostate cancer remains a significant global health challenge, impacting millions of men each year. In 2022, more than 1.4 million new cases were reported worldwide, ( 1 ) with projections estimating 313,780 new diagnoses in the United States by 2025 ( 2 ). In the UK, prostate cancer accounts for 28% of all new cancer cases in males, with approximately 1 in 8 men being diagnosed over their lifetime ( 3 ). As  one Sermo member  specializing in oncology put it: “Prostate cancer is the #2 cancer killer in men. We need to do something. 4 ” This highlights the urgent need for effective prevention, treatment and awareness initiatives.In this article, we delve into the treatments currently used, as mentioned by doctors inside Sermo’s free physician-only community, and explore the  latest advancements  shaping the future of prostate cancer care. What current treatments do physicians on Sermo use? Physicians on Sermo constantly refine their approaches to provide personalized,...

Despite  trillions spent on cancer research , cancer still  kills around 10 million people a year  and is a leading cause of death globally, according to the World Health Organization. Cancer research continues to advance at an unprecedented pace, with new treatments offering hope to millions of patients worldwide.   Credit:  Statista Breast, lung and colon cancer are among the most common, while the number of new cancer cases annually is expected to grow by more than 75% between 2022 and 2050. As we enter 2025, several groundbreaking therapies and innovations—including personalized vaccines, gene-editing technologies, repurposed drugs, and alternative cancer treatments —are reshaping cancer care. Here are some of the most promising breakthroughs to watch for this year: 1. Next-Generation Immunotherapy Perhaps the most transformative breakthrough in modern oncology has been the rise of immunotherapy—a set of treatments that awaken the immune system to reco...